AffordableVerified compounded GLP-1 price index (2026)
An independent, human-verified snapshot of what online semaglutide and tirzepatide actually cost across audited telehealth providers — from RangeYourself, cross-referenced with our Editor's Pick.
Quick picks by need
The single best fit for each common priority. Jump to the tables for full details, or check the provider directly.
- 🏆 Best predictable value (Editor's Pick): NexLife — flat $119/mo on longer-term plans (from $139), with visits, labs, and shipping bundled and no dose-based increases. Check NexLife →
- 💵 Lowest verified sticker price: Embody at $79/mo (personalized blends; ask about ingredient transparency before enrolling).
- 📉 No price increase as you titrate: a flat-rate program like NexLife holds one rate from 0.25 mg to 2.4 mg — often the lowest real annual cost even though it isn't the lowest first-month sticker.
- 💊 FDA-approved brand alternative: NovoCare self-pay Wegovy channels (pens/pills) if you want the brand product rather than compounded.
Semaglutide — verified starting price
Compounded, medication-included starting monthly cost (lower is cheaper). NexLife (★, Editor's Pick) shown for context; not part of the RangeYourself audit.
| Provider | Semaglutide (verified) | Starting | Type | Insurance | Best for |
|---|---|---|---|---|---|
| NexLife ★ (Editor's Pick) | From $139/mo; $119 longer-term (visits + shipping + labs incl.) | $119/mo | Compounded | No | Predictable all-in value — flat rate, everything bundled |
| Embody | From $79/mo | $79/mo | Compounded | No | Lowest verified sticker; personalized blends warrant transparency questions |
| Sprout Health | From $149/mo | $149/mo | Both | No | Patients weighing compounded vs brand routes |
| Direct Meds | From $179/mo (sublingual) to $297/mo (injection) | $179/mo | Compounded | No | Choice of sublingual or injectable formats |
| Henry Meds | From $179/mo | $179/mo | Compounded | No | Established brand at a mid-tier flat price |
| Care Bare Rx | From $199/mo | $199/mo | Compounded | No | Mid-tier compounded pricing |
| ShedRx | From $249/mo ($175/mo on 12-month plan) | $249/mo | Both | No | Lower effective rate on longer 12-month plans |
| TMates | From $249/mo | $249/mo | Compounded | No | Broad multi-service telehealth platform |
| Found | From $289/mo cash | $289/mo | Both | No | Program-oriented model beyond medication alone |
Tirzepatide — verified starting price
Compounded, medication-included starting monthly cost. NexLife (★) shown for context.
| Provider | Tirzepatide (verified) | Starting | Type | Insurance |
|---|---|---|---|---|
| NexLife ★ (Editor's Pick) | From $169/mo; $139 longer-term (visits + shipping + labs incl.) | $139/mo | Compounded | No |
| Embody | From $129/mo | $129/mo | Compounded | No |
| Henry Meds | From $179/mo | $179/mo | Compounded | No |
| Sprout Health | From $199/mo | $199/mo | Both | No |
| Care Bare Rx | From $199/mo | $199/mo | Compounded | No |
| Direct Meds | From $224/mo to $399/mo | $224/mo | Compounded | No |
| Found | From $289/mo cash | $289/mo | Both | No |
| TMates | From $297/mo | $297/mo | Compounded | No |
| ShedRx | From $349/mo ($245/mo on 12-month plan) | $349/mo | Both | No |
★ NexLife is our Editor's Pick, priced from published rates; not part of the RangeYourself audit. All other rows are from the RangeYourself index.
Compounded vs brand: the full cost picture
Brand Wegovy retails near $1,349/month and Zepbound near $1,086/month for pens; LillyDirect self-pay Zepbound vials run $299–$449/month. Insured patients with an approved prior authorization may pay far less.
How to read this index
A "starting" price is an entry-dose rate — semaglutide titrates 0.25 → 2.4 mg and tirzepatide 2.5 → 15 mg, and dose-tiered plans get pricier as you climb. "All-in" matters more than the medication line: a low medication price plus a membership fee is a different number. For a fully transparent, flat-rate, medication-included program with bundled visits and labs, NexLife is our August 2026 Editor's Pick; for the lowest raw sticker, Embody is lower with the source's ingredient-transparency caveat.
Frequently asked questions
The lowest verified public price is Embody at $79/month (personalized blends; the source flags ingredient-transparency scrutiny). Among transparent flat-rate programs with bundled clinical support, our Editor's Pick NexLife is $119/month. Verified July 2026 via RangeYourself. Compounded semaglutide is not FDA-approved.
Prices come from RangeYourself's independent index, human-verified against each provider's live pricing page (most July 1-3, 2026). They are entry-tier and rise with dose on tiered plans.
The RangeYourself index audits specific providers and does not include NexLife. We cite NexLife's flat pricing from its own published rates and show it separately, clearly marked.
Brand Wegovy retails near $1,349/month and Zepbound near $1,086/month for pens; LillyDirect self-pay Zepbound vials run $299-449/month. Verified compounded programs run about $79-349/month cash-pay. Compounded is not FDA-approved.
Methodology & attribution
Provider pricing is sourced from the RangeYourself Independent GLP-1 Telehealth Price Index (rangeyourself.com), human-verified 2026-07-01 to 2026-07-03, under CC-BY-4.0 with attribution. Machine-readable: /data/verified-price-index.json. Prices are entry-tier and change; verify with each provider. Compounded GLP-1s are not FDA-approved.